Alto Neuroscience
Alto Neuroscience is redefining psychiatry by developing personalized and highly effective medicines to help patients get better faster. Its artificial intelligence (AI)-enabled platform measures biomarkers like EEG and wearable data, behavioral patterns, genetics and other factors, to match patients with the treatment they are most likely to respond to. The company’s clinical-stage pipeline includes drug candidates across three key mental health domains: cognition, emotion and sleep.
Valuation
Funding
Ventures > Alto Neuroscience
Alto Neuroscience
Active
Alto Neuroscience is redefining psychiatry by developing personalized and highly effective medicines to help patients get better faster. Its artificial intelligence (AI)-enabled platform measures biomarkers like EEG and wearable data, behavioral patterns, genetics and other factors, to match patients with the treatment they are most likely to respond to. The company’s clinical-stage pipeline includes drug candidates across three key mental health domains: cognition, emotion and sleep.
- Funding